Unity Stock Based Compensation from 2010 to 2024

UBX Stock

USD 1.24 0.03 2.48%

Unity Biotechnology Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2017-03-31

Previous Quarter

974 K

Current Value

797 K

Quarterly Volatility

1 M

Covid

Check Unity Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Unity Biotechnology's main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.5 M or Interest Expense of 1.9 M, as well as many indicators such as Price To Sales Ratio of 104, Dividend Yield of 0.0 or PTB Ratio of 1.07. Unity financial statements analysis is a perfect complement when working with Unity Biotechnology Valuation or Volatility modules.

Check out the analysis of Unity Biotechnology Correlation against competitors.

For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.

Latest Unity Biotechnology's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Unity Biotechnology over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Unity Biotechnology's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Unity Biotechnology's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Unity Stock Based Compensation Regression Statistics

	Arithmetic Mean	5,072,988
	Geometric Mean	1,571,745
	Coefficient Of Variation	102.61
	Mean Deviation	4,797,587
	Median	3,034,000
	Standard Deviation	5,205,427
	Sample Variance	27.1T
	Range	13.6M
	R-Value	0.82
	Mean Square Error	9.6T
	R-Squared	0.67
	Significance	0.0002
	Slope	954,227
	Total Sum of Squares	379.4T

Unity Stock Based Compensation History

	2024	9 M
	2023	7.4 M
	2022	9.4 M
	2021	11.6 M
	2020	13.8 M
	2019	10.9 M
	2018	9.4 M

Other Fundumenentals of Unity Biotechnology

Stock Based Compensation To Revenue

Unity Biotechnology Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Net Receivables	Long Term Debt Total	Net Invested Capital	Net Working Capital	Deferred Long Term Liab	Capital Stock	Current Deferred Revenue	Short Term Debt	Long Term Debt	Short Long Term Debt
Total Assets		0.78	0.7	0.42	-0.17	0.83	0.29	-0.46	0.86	0.65	0.48	-0.88	0.43	0.77	0.83	0.22	0.35	0.4	0.13	0.25	-0.3
Total Stockholder Equity	0.78		0.78	0.75	-0.52	0.9	0.59	-0.91	0.55	0.76	0.53	-0.78	0.55	0.4	0.54	0.5	0.07	0.25	0.3	-0.18	0.13
Net Tangible Assets	0.7	0.78		0.67	-0.7	0.77	0.81	-0.67	0.46	0.67	0.55	-0.78	0.67	0.22	0.43	0.68	-0.04	0.27	0.42	-0.39	0.34
Net Debt	0.42	0.75	0.67		-0.88	0.45	0.86	-0.81	-0.01	0.67	0.74	-0.65	0.67	-0.16	-0.05	0.79	-0.18	0.47	0.76	-0.62	0.52
Retained Earnings	-0.17	-0.52	-0.7	-0.88		-0.29	-0.98	0.66	0.23	-0.53	-0.65	0.5	-0.7	0.45	0.28	-0.9	0.34	-0.28	-0.83	0.85	-0.75
Accounts Payable	0.83	0.9	0.77	0.45	-0.29		0.42	-0.74	0.73	0.72	0.39	-0.72	0.52	0.55	0.73	0.33	0.23	0.12	0.01	0.08	-0.09
Capital Surpluse	0.29	0.59	0.81	0.86	-0.98	0.42		-0.7	-0.07	0.62	0.67	-0.57	0.71	-0.34	-0.12	0.87	-0.25	0.26	0.76	-0.78	0.67
Total Liab	-0.46	-0.91	-0.67	-0.81	0.66	-0.74	-0.7		-0.22	-0.69	-0.46	0.53	-0.51	-0.01	-0.23	-0.57	0.13	-0.1	-0.37	0.44	-0.39
Total Current Assets	0.86	0.55	0.46	-0.01	0.23	0.73	-0.07	-0.22		0.33	0.02	-0.6	0.0	0.9	0.99	-0.22	0.32	0.01	-0.22	0.48	-0.48
Common Stock	0.65	0.76	0.67	0.67	-0.53	0.72	0.62	-0.69	0.33		0.86	-0.72	0.68	0.18	0.31	0.58	0.54	0.4	0.26	-0.06	-0.12
Property Plant Equipment	0.48	0.53	0.55	0.74	-0.65	0.39	0.67	-0.46	0.02	0.86		-0.67	0.8	-0.04	-0.02	0.73	0.42	0.7	0.5	-0.2	0.02
Net Receivables	-0.88	-0.78	-0.78	-0.65	0.5	-0.72	-0.57	0.53	-0.6	-0.72	-0.67		-0.64	-0.5	-0.53	-0.57	-0.22	-0.39	-0.52	0.11	0.01
Long Term Debt Total	0.43	0.55	0.67	0.67	-0.7	0.52	0.71	-0.51	0.0	0.68	0.8	-0.64		-0.07	-0.05	0.89	0.11	0.6	0.46	-0.33	0.28
Net Invested Capital	0.77	0.4	0.22	-0.16	0.45	0.55	-0.34	-0.01	0.9	0.18	-0.04	-0.5	-0.07		0.89	-0.31	0.42	0.11	-0.35	0.67	-0.63
Net Working Capital	0.83	0.54	0.43	-0.05	0.28	0.73	-0.12	-0.23	0.99	0.31	-0.02	-0.53	-0.05	0.89		-0.28	0.33	-0.01	-0.3	0.52	-0.5
Deferred Long Term Liab	0.22	0.5	0.68	0.79	-0.9	0.33	0.87	-0.57	-0.22	0.58	0.73	-0.57	0.89	-0.31	-0.28		-0.14	0.39	0.71	-0.68	0.6
Capital Stock	0.35	0.07	-0.04	-0.18	0.34	0.23	-0.25	0.13	0.32	0.54	0.42	-0.22	0.11	0.42	0.33	-0.14		0.24	-0.42	0.69	-0.84
Current Deferred Revenue	0.4	0.25	0.27	0.47	-0.28	0.12	0.26	-0.1	0.01	0.4	0.7	-0.39	0.6	0.11	-0.01	0.39	0.24		0.22	0.09	-0.08
Short Term Debt	0.13	0.3	0.42	0.76	-0.83	0.01	0.76	-0.37	-0.22	0.26	0.5	-0.52	0.46	-0.35	-0.3	0.71	-0.42	0.22		-0.79	0.64
Long Term Debt	0.25	-0.18	-0.39	-0.62	0.85	0.08	-0.78	0.44	0.48	-0.06	-0.2	0.11	-0.33	0.67	0.52	-0.68	0.69	0.09	-0.79		-0.95
Short Long Term Debt	-0.3	0.13	0.34	0.52	-0.75	-0.09	0.67	-0.39	-0.48	-0.12	0.02	0.01	0.28	-0.63	-0.5	0.6	-0.84	-0.08	0.64	-0.95

Click cells to compare fundamentals

About Unity Biotechnology Financial Statements

Unity Biotechnology investors use historical fundamental indicators, such as Unity Biotechnology's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Unity Biotechnology. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	7.4 M	9 M
Stock Based Compensation To Revenue	35.77	37.56

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Unity Stock Analysis

When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Unity Stock Based Compensation from 2010 to 2024

Latest Unity Biotechnology's Stock Based Compensation Growth Pattern

Unity Stock Based Compensation Regression Statistics

Unity Stock Based Compensation History

Other Fundumenentals of Unity Biotechnology

Unity Biotechnology Stock Based Compensation component correlations

About Unity Biotechnology Financial Statements

Also Currently Popular

Additional Tools for Unity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY